The Global Point of Care Molecular Diagnostics Market size is expected to grow at an annual average of 13% during 2021-2027. Molecular diagnostics have been carried out in centralized laboratories for many years. However, several drawbacks such as delayed results, high test cost, low accuracy, and late disease diagnosis increase mortality and hinder the growth of this market.
(Get 15% Discount on Buying this Report)
A full report of Global Point of Care Molecular Diagnostics Market is available at: https://www.orionmarketreports.com/point-of-care-poc-molecular-diagnostics-market/10678/
The following Segmentation are covered in this report:
Market, by Product & Service
- Assays & Kits
- Instruments/Analyzers
- Services & Software
Market, by Application
- Respiratory diseases
- STDs
- HAIs
- Oncology
- Hepatitis
- Other Applications
Market, by Technology
- RT-PCR
- INAAT
- Others Technologies
Market, by End User
- Physician Offices
- Hospital Emergency Departments & Intensive Care Units
- Research Institutes
- Other End User
The report covers the following objectives:
- Proliferation and maturation of trade in the global Point of Care Molecular Diagnostics Market.
- The market share of the global Point of Care Molecular Diagnostics Market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Point of Care Molecular Diagnostics Market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Point of Care Molecular Diagnostics Market.
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
